Lixisenatide: A New Member of the Glucagon-Like Peptide 1 Receptor Agonist Class of Incretin Therapies.
Saved in:
| Title: | Lixisenatide: A New Member of the Glucagon-Like Peptide 1 Receptor Agonist Class of Incretin Therapies. |
|---|---|
| Authors: | Shaefer Jr., Charles F.1 cshaefer@uh.org |
| Source: | Clinical Diabetes. Spring2016, Vol. 34 Issue 2, p81-85. 5p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
